The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Charge‐Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery
Abstract
DNA‐toxin anticancer drugs target nuclear DNA or its associated enzymes to elicit their pharmaceutical effects, but cancer cells have not only membrane‐associated but also many intracellular drug‐resistance mechanisms that limit their nuclear localization. Thus, delivering such drugs directly to the nucleus would bypass the drug‐resistance barriers. The cationic polymer poly(L‐lysine) (PLL) is capable of nuclear localization and may be used as a drug carrier for nuclear drug delivery, but its cationic charges make it toxic and cause problems in in‐vivo applications. Herein, PLL is used to demonstrate a pH‐triggered charge‐reversal carrier to solve this problem. PLL's primary amines are amidized as acid‐labile β‐carboxylic amides (PLL/amide). The negatively charged PLL/amide has a very low toxicity and low interaction with cells and, therefore, may be used in vivo. But once in cancer cells' acidic lysosomes, the acid‐labile amides hydrolyze into primary amines. The regenerated PLL escapes from the lysosomes and traverses into the nucleus. A cancer‐cell targeted nuclear‐localization polymer–drug conjugate has, thereby, been developed by introducing folic‐acid targeting groups and an anticancer drug camptothecin (CPT) to PLL/amide (FA‐PLL/amide‐CPT). The conjugate efficiently enters folate‐receptor overexpressing cancer cells and traverses to their nuclei. The CPT conjugated to the carrier by intracellular cleavable disulfide bonds shows much improved cytotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., & Kissel, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00445-3 · Cited by 2,329
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
Classical Nuclear Localization Signals: Definition, Function, and Interaction with Importin α
Lange, A., Mills, R. E., Lange, C. J., Stewart, M., Devine, S. E., & Corbett, A. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600026200 · Cited by 1,146
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Nuclear Pore Complex Is Able to Transport Macromolecules with Diameters of ∼39 nm
Panté, N., & Kann, M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-06-0308 · Cited by 776
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Modern trends in polymer bioconjugates design
Lutz, J.-F., & Börner, H. G. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.07.005 · Cited by 545
Tumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506
Polylysine-based transfection systems utilizing receptor-mediated delivery
Zauner, W., Ogris, M., & Wagner, E. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00110-5 · Cited by 504
New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy
Park, K., Lee, S., Kang, E., Kim, K., Choi, K., & Kwon, I. C. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200801655 · Cited by 432
A Protein Nanocarrier from Charge-Conversion Polymer in Response to Endosomal pH
Lee, Y., Fukushima, S., Bae, Y., Hiki, S., Ishii, T., & Kataoka, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071090b · Cited by 404
The design and synthesis of polymers for eukaryotic membrane disruption
Murthy, N., Robichaud, J. R., Tirrell, D. A., Stayton, P. S., & Hoffman, A. S. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00114-5 · Cited by 403
Takae, S., Miyata, K., Oba, M., Ishii, T., Nishiyama, N., Itaka, K., Yamasaki, Y., Koyama, H., & Kataoka, K. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800336v · Cited by 400
Moore, M. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.242 · Cited by 397
Poly(amidoamine) Dendrimer-Based Multifunctional Engineered Nanodevice for Cancer Therapy
Majoros, I. J., Thomas, T. P., Mehta, C. B., & Baker, J. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0401863 · Cited by 395
Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
Wall, M. E., & Wani, M. C. (1995) · PubMed · Cited by 376
Targeted Charge‐Reversal Nanoparticles for Nuclear Drug Delivery
Xu, P., Van Kirk, E. A., Zhan, Y., Murdoch, W. J., Radosz, M., & Shen, Y. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200605254 · Cited by 370
Self-citationBlock copolymer micelles for drug delivery: loading and release of doxorubicin
Kwon, G., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00039-4 · Cited by 320
Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging
Yang, J., Chen, H., Vlahov, I. R., Cheng, J.-X., & Low, P. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601455103 · Cited by 318
Anticancer Polymeric Nanomedicines
Tong, R., & Cheng, J. (2007) · Polymer Reviews · doi:10.1080/15583720701455079 · Cited by 310
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
NORI, A., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.006 · Cited by 303
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Kolhatkar, R. B., Kitchens, K. M., Swaan, P. W., & Ghandehari, H. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603889 · Cited by 287
Camptothecin and taxol: from discovery to clinic
Wall, M. E., & Wani, M. C. (1996) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01367-9 · Cited by 264
Ligand-Targeted Liposomes for Cancer Treatment
Sapra, P., Tyagi, P., & Allen, T. (2005) · Current Drug Delivery · doi:10.2174/156720105774370159 · Cited by 246
Dendrimeric micelles for controlled drug release and targeted delivery
Ambade, A. V., Savariar, E. N., & Thayumanavan, S. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050020d · Cited by 245
Lee, Y., Miyata, K., Oba, M., Ishii, T., Fukushima, S., Han, M., Koyama, H., Nishiyama, N., & Kataoka, K. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800963 · Cited by 229
Soppimath, K. S., Liu, L. ‐., Seow, W. Y., Liu, S. ‐., Powell, R., Chan, P., & Yang, Y. Y. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200500611 · Cited by 188
Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells
Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9415-0 · Cited by 182
Wang, G., Reed, E., & Li, Q. (2004) · Oncology Reports · doi:10.3892/or.12.5.955 · Cited by 170
Reversible Covalent Chemistry in Drug Delivery
West, K., & Otto, S. (2005) · Current Drug Discovery Technologies · doi:10.2174/1570163054866882 · Cited by 166
Synthesis and activity of a folate peptide camptothecin prodrug
Henne, W. A., Doorneweerd, D. D., Hilgenbrink, A. R., Kularatne, S. A., & Low, P. S. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.076 · Cited by 157
Oba, M., Aoyagi, K., Miyata, K., Matsumoto, Y., Itaka, K., Nishiyama, N., Yamasaki, Y., Koyama, H., & Kataoka, K. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800070s · Cited by 152
Polymer Therapeutics for Cancer: Current Status and Future Challenges
Satchi‐Fainaro, R., Duncan, R., & Barnés, C. M. (2005) · Springer eBooks · doi:10.1007/12_024 · Cited by 146
Farrell, L.-L., Pepin, J., Kucharski, C., Lin, X., Xu, Z., & Uludağ, H. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.026 · Cited by 105
Degradable Poly(β-amino ester) nanoparticles for cancer cytoplasmic drug delivery
Shen, Y., Tang, H., Zhan, Y., Kirk, E. A. V., & Murdoch, W. J. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.09.003 · Cited by 102
Self-citationPotential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9572-9 · Cited by 100
Duvvuri, M. (2005) · Frontiers in bioscience · doi:10.2741/1634 · Cited by 98
Engineered Nanocarriers of Doxorubicin: A Current Update
Patil, R., Guhagarkar, S. A., & Devarajan, P. V. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i1.10 · Cited by 94
ElSayed, M. E. H., Hoffman, A. S., & Stayton, P. S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.009 · Cited by 88
Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targeting
Mitra, A., Coleman, T., Borgman, M. P., Nan, A., Ghandehari, H., & Line, B. R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.014 · Cited by 82
Lee, H., & Pardridge, W. M. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0256648 · Cited by 78
Molinari, A., Calcabrini, A., Meschini, S., Stringaro, A., Crateri, P., Toccacieli, L., Marra, M., Colone, M., Cianfriglia, M., & Arancia, G. (2002) · Current Protein and Peptide Science · doi:10.2174/1389203023380413 · Cited by 78
Klink, D. T., Chao, S., Glick, M. C., & Scanlin, T. F. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0332 · Cited by 61
Miotti, S., Bagnoli, M., Ottone, F., Tomassetti, A., COLNAGHI, M. I., & Canevari, S. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970615)65:4<479::aid-jcb4>3.0.co;2-l · Cited by 57
Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats.
Worrell, N. R., Cumber, A. J., Parnell, G. D., Mirza, A., Forrester, J. A., & Ross, W. C. J. (1986) · PubMed · Cited by 46
Endosomes as a route for drug delivery in the real world
Sheff, D. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.11.005 · Cited by 33
Cited by
Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172
pH-Sensitive nano-systems for drug delivery in cancer therapy
Liu, J., Huang, Y., Kumar, A., Tan, A., Jin, S., Mozhi, A., & Liang, X.-J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.009 · Cited by 1,121
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Self-citationGe, Z., & Liu, S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60048c · Cited by 914
Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
Zhou, Q., Shao, S., Wang, J., Xu, C., Xiang, J., Piao, Y., Zhou, Z., Yu, Q., Tang, J., Liu, X., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0485-z · Cited by 819
Self-citation
Metadata
- Authors
- Zhou, Z., Shen, Y., Tang, J., Fan, M., Van Kirk, E. A., Murdoch, W. J., & Radosz, M.
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2009-11-20
- Volume
- 19
- Issue
- 22
- Pages
- 3580-3589
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W2159227890
- Cited by
- 311
- References
- 52
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.